Brian Thomas Walsh - Net Worth and Insider Trading
Brian Thomas Walsh Net Worth
The estimated net worth of Brian Thomas Walsh is at least $4,368 dollars as of 2024-12-15. Brian Thomas Walsh is the Senior Officer of HLS Therapeutics Inc and owns about 1,200 shares of HLS Therapeutics Inc (TSX:HLS) stock worth over $4,368. Details can be seen in Brian Thomas Walsh's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Brian Thomas Walsh has not made any transactions after 2023-11-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Brian Thomas Walsh
Brian Thomas Walsh Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Brian Thomas Walsh owns 1 companies in total, including HLS Therapeutics Inc (TSX:HLS) .
Click here to see the complete history of Brian Thomas Walsh’s form 4 insider trades.
Insider Ownership Summary of Brian Thomas Walsh
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:HLS | HLS Therapeutics Inc | 2023-11-15 | Senior Officer |
Brian Thomas Walsh Latest Holdings Summary
Brian Thomas Walsh currently owns a total of 1 stock. Brian Thomas Walsh owns 1,200 shares of HLS Therapeutics Inc (TSX:HLS) as of November 15, 2023, with a value of $4,368.
Latest Holdings of Brian Thomas Walsh
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:HLS | HLS Therapeutics Inc | 2023-11-15 | 1,200 | 3.64 | 4,368 |
Holding Weightings of Brian Thomas Walsh
Brian Thomas Walsh Form 4 Trading Tracker
According to the SEC Form 4 filings, Brian Thomas Walsh has made a total of 2 transactions in HLS Therapeutics Inc (TSX:HLS) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in HLS Therapeutics Inc is the acquisition of 1,000 shares on November 15, 2023, which cost Brian Thomas Walsh around $3,939.
Insider Trading History of Brian Thomas Walsh
- 1
Brian Thomas Walsh Trading Performance
GuruFocus tracks the stock performance after each of Brian Thomas Walsh's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Brian Thomas Walsh is 1.93%. GuruFocus also compares Brian Thomas Walsh's trading performance to market benchmark return within the same time period. The performance of stocks bought by Brian Thomas Walsh within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Brian Thomas Walsh's insider trading performs compared to the benchmark.
Performance of Brian Thomas Walsh
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -6.94 | | | | | |
| Relative Return to S&P 500(%) | -12.69 | | | | | |
Brian Thomas Walsh Ownership Network
Ownership Network List of Brian Thomas Walsh
Ownership Network Relation of Brian Thomas Walsh
Brian Thomas Walsh Owned Company Details
What does HLS Therapeutics Inc do?
Who are the key executives at HLS Therapeutics Inc?
Brian Thomas Walsh is the Senior Officer of HLS Therapeutics Inc. Other key executives at HLS Therapeutics Inc include Director & Senior Officer Craig Millian , 10% Security Holder Polar Asset Management Partners Inc. , and Director & Senior Officer John Gordon Hanna .
HLS Therapeutics Inc (TSX:HLS) Insider Trades Summary
Over the past 18 months, Brian Thomas Walsh made 2 insider transaction in HLS Therapeutics Inc (TSX:HLS) with a net purchase of 1,200. Other recent insider transactions involving HLS Therapeutics Inc (TSX:HLS) include a net purchase of 32,400 shares made by Polar Asset Management Partners Inc. , a net purchase of 7,500 shares made by Craig Millian , and a net sale of 1,300,000 shares made by Athyrium Opportunities II Co-Invest 1 LP .
In summary, during the past 3 months, insiders sold 500 shares of HLS Therapeutics Inc (TSX:HLS) in total and bought 0 shares, with a net sale of 500 shares. During the past 18 months, 1,300,500 shares of HLS Therapeutics Inc (TSX:HLS) were sold and 45,100 shares were bought by its insiders, resulting in a net sale of 1,255,400 shares.
HLS Therapeutics Inc (TSX:HLS)'s detailed insider trading history can be found in Insider Trading Tracker table.
HLS Therapeutics Inc Insider Transactions
Brian Thomas Walsh Mailing Address
Above is the net worth, insider trading, and ownership report for Brian Thomas Walsh. Currently GuruFocus does not have mailing address information for Brian Thomas Walsh.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
